Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

Assessing lifestyle-related diseases with body and muscle mass using bioelectrical impedance analysis

Miyagami T, Yokokawa H, Fujibayashi K, Fukuda H, Hisaoka T, Naito T

  • Osteoporos Sarcopenia.
  • 2020 Mar;6(1):27-32.
  • doi: 10.1016/j.afos.2020.02.004
Objectives: To investigate the correlation between imbalance of muscle mass to body weight and lifestyle-related diseases using bioelectrical impedance analysis (BIA) among Japanese population. Methods: This was a retrospective, cross-sectional study...
Association between elcatonin use and cancer risk in Japan: A followup study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis

Okamoto H, Shibazaki N, Yoshimura T, Uzawa T, Sugimoto T

  • Osteoporos Sarcopenia.
  • 2020 Mar;6(1):15-19.
  • doi: 10.1016/j.afos.2020.02.001
Objectives: On July 20, 2012, the European Medicines Agency (EMA) provided a recommendation that limits the long-term use of calcitonin. Based on this recommendation, we investigate the presence or absence...
Management of glucocorticoid-related osteoporotic vertebral fracture

Wong SPY, Mok CC

  • Osteoporos Sarcopenia.
  • 2020 Mar;6(1):1-7.
  • doi: 10.1016/j.afos.2020.02.002
The vertebral column is the most common site of osteoporotic fractures in long-term users of glucocorticoids. Vertebral fracture leads to significant morbidities such as unrelenting pain, spinal deformities and reduced...
Reply on "Coffee consumption and bone health: A risk assessment"

Coronado-Zarco R, Leon AOGd

  • Osteoporos Sarcopenia.
  • 2020 Mar;6(1):34-35.
  • doi: 10.1016/j.afos.2020.02.006
Letter to the editor: Coffee consumption and bone health: A risk assessment

Kawada T

  • Osteoporos Sarcopenia.
  • 2020 Mar;6(1):33-33.
  • doi: 10.1016/j.afos.2020.02.005
Risk of falls in postmenopausal women treated with romosozumab: Preliminary indices from a meta-analysis of randomized, controlled trials

M€ockel L, Bartneck M, M€ockel C

  • Osteoporos Sarcopenia.
  • 2020 Mar;6(1):20-26.
  • doi: 10.1016/j.afos.2020.02.003
Objectives: Falls are the well-known risk factor for osteoporotic fractures and some medications can increase the risk of falls. Therefore, the aim of our study is to evaluate the effect...
Effects of treatment interruption due to patient convenience on treatment of once a week teriparatide

Katahira G, Akiba K, Takada J, Iba K, Yamashita T

  • Osteoporos Sarcopenia.
  • 2020 Mar;6(1):8-14.
  • doi: 10.1016/j.afos.2020.01.001
Objectives: Once-weekly teriparatide (W-TPTD) is an effective drug for patients with osteoporosis; however, some patients discontinue W-TPTD owing to its adverse drug reactions (ADRs). Sequential treatment with W-TPTD and antiresorptive...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr